Home › Waldenstrom Macroglobulinemia › Minnesota › Rochester
Waldenstrom Macroglobulinemia clinical trials in Rochester, MN
6 studies for Waldenstrom Macroglobulinemia are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Mayo Clinic Rochester, Rochester
ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia
RecruitingPhase 1/2
- Mayo Clinic in Rochester, Rochester
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Mayo Clinic - Rochester, Rochester
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
RecruitingObservational study
- Mayo Clinic in Rochester, Rochester
Q702 for the Treatment of Patients With Hematologic Malignancies
RecruitingPhase 1
- Mayo Clinic in Rochester, Rochester
Waldenstrom Macroglobulinemia trials in other cities
- Durham, NC10 studies
- Boston, MA9 studies
- Denver, CO7 studies
- Houston, TX6 studies
- New York City, NY6 studies
- Dallas, TX6 studies
- Edison, NJ6 studies
- Seattle, WA5 studies
- Milwaukee, WI5 studies
- Washington, DC4 studies
- Baldwin Park, CA4 studies
- Columbus, OH4 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Multiple Myeloma24 studies
- Heart Failure22 studies
- Prostate Cancer22 studies
- Pancreatic Cancer22 studies
- Endometrial Cancer20 studies
- Lung Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.